Trial Profile
Pharmacokineticsof the active components of anextrafineformulation of beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide (BDP/FF/G)delivered via a hydrofluoroalkane 134-a pressurized-metered dose inhaler (HFA pMDI) in Chinese healthy adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Oct 2020
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Chiesi Farmaceutici
- 02 Nov 2018 New trial record